Protocol for a randomized controlled trial of Xueshuantong injection on myocardial injury and residual cardiovascular risk in patients with unstable angina
This exploratory study will evaluate the efficacy and safety of XST in reducing myocardial injury and residual risk in UA patients, providing evidence for future large-scale confirmatory trials.
Authors
- Yan‐Ming Xie (ORCID: https://orcid.org/0000-0001-5359-4242)
- Yutong Ma (ORCID: https://orcid.org/0000-0002-0622-2793)
- Junyu Xi
- Yaxin Wang (ORCID: https://orcid.org/0000-0002-3507-3969)
- Guangyu Liu
- Weiyi Feng (ORCID: https://orcid.org/0000-0003-0581-6773)
- Zhenkai Lu
- Jian Lyu (ORCID: https://orcid.org/0000-0001-6518-622X)
Institutions
- Beijing University of Chinese Medicine (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Wangjing Hospital of China Academy of Chinese Medical Sciences (CN)
- Xiyuan Hospital (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-10-21
- DOI
- https://doi.org/10.3389/fcvm.2025.1602666
- Primary Topic
- Cardiac Imaging and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00